+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666008
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bone Marrow Transplantation Market size was estimated at USD 16.27 billion in 2023, USD 17.62 billion in 2024, and is expected to grow at a CAGR of 8.74% to reach USD 29.26 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bone Marrow Transplantation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bone Marrow Transplantation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bone Marrow Transplantation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Type Culture Collection, Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol Myers Squibb, Eli Lilly and Company, FUJIFILM Cellular Dynamics, Inc., Gamida Cell, Hemacare Corporation, Lifeline Cell Technology, Lonza Group AG, Magenta Therapeutics, Inc., Merck KgaA, Mesoblast Ltd., Novartis AG, PromoCell GmbH, Qiagen N.V., ReeLabs Pvt. Ltd., Sanofi-Aventis LLC, ScienCell Research Laboratories, Inc., and STEMCELL Technologies Inc.

Market Segmentation & Coverage

This research report categorizes the Bone Marrow Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Allogeneic Transplant
    • Autologous Transplant
  • Treatment Type
    • Aplastic Anemia
    • Leukemia
    • Lymphoma
    • Myelodysplastic Syndrome
    • Myeloma
    • Myeloproliferative Disorders
    • Sickle cell Anemia
    • Solid Tumors
    • Thalassemia
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Multi-Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Bone Marrow Transplantation Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bone Marrow Transplantation Market?
  3. What are the technology trends and regulatory frameworks in the Bone Marrow Transplantation Market?
  4. What is the market share of the leading vendors in the Bone Marrow Transplantation Market?
  5. Which modes and strategic moves are suitable for entering the Bone Marrow Transplantation Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Bone Marrow Transplantation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of blood cancer and improving accessibility to bone marrow transplantation
5.1.1.2. Increased commercialization of cell therapy and tissue engineering products
5.1.1.3. Government initiatives to improve awareness of the therapy
5.1.2. Restraints
5.1.2.1. High cost of the treatment and lack of reimbursement
5.1.3. Opportunities
5.1.3.1. Technological advancements in bone marrow transplantation therapy
5.1.3.2. Ongoing research & development activities of BMT
5.1.4. Challenges
5.1.4.1. Concerns related to GVHD, infections and relapse
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Bone Marrow Transplantation Market, by Type
6.1. Introduction
6.2. Allogeneic Transplant
6.3. Autologous Transplant
7. Bone Marrow Transplantation Market, by Treatment Type
7.1. Introduction
7.2. Aplastic Anemia
7.3. Leukemia
7.4. Lymphoma
7.5. Myelodysplastic Syndrome
7.6. Myeloma
7.7. Myeloproliferative Disorders
7.8. Sickle cell Anemia
7.9. Solid Tumors
7.10. Thalassemia
8. Bone Marrow Transplantation Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Multi-Specialty Clinics
9. Americas Bone Marrow Transplantation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bone Marrow Transplantation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Bone Marrow Transplantation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. American Type Culture Collection
13.1.3. Bayer AG
13.1.4. Becton, Dickinson and Company
13.1.5. Bio-Rad Laboratories, Inc.
13.1.6. Bristol Myers Squibb
13.1.7. Eli Lilly and Company
13.1.8. FUJIFILM Cellular Dynamics, Inc.
13.1.9. Gamida Cell
13.1.10. Hemacare Corporation
13.1.11. Lifeline Cell Technology
13.1.12. Lonza Group AG
13.1.13. Magenta Therapeutics, Inc.
13.1.14. Merck KgaA
13.1.15. Mesoblast Ltd.
13.1.16. Novartis AG
13.1.17. PromoCell GmbH
13.1.18. Qiagen N.V.
13.1.19. ReeLabs Pvt. Ltd.
13.1.20. Sanofi-Aventis LLC
13.1.21. ScienCell Research Laboratories, Inc.
13.1.22. STEMCELL Technologies Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BONE MARROW TRANSPLANTATION MARKET RESEARCH PROCESS
FIGURE 2. BONE MARROW TRANSPLANTATION MARKET SIZE, 2023 VS 2030
FIGURE 3. BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BONE MARROW TRANSPLANTATION MARKET DYNAMICS
FIGURE 7. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 10. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Abbott Laboratories
  • American Type Culture Collection
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • FUJIFILM Cellular Dynamics, Inc.
  • Gamida Cell
  • Hemacare Corporation
  • Lifeline Cell Technology
  • Lonza Group AG
  • Magenta Therapeutics, Inc.
  • Merck KgaA
  • Mesoblast Ltd.
  • Novartis AG
  • PromoCell GmbH
  • Qiagen N.V.
  • ReeLabs Pvt. Ltd.
  • Sanofi-Aventis LLC
  • ScienCell Research Laboratories, Inc.
  • STEMCELL Technologies Inc.

Methodology

Loading
LOADING...

Table Information